Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHODS OF IDENTIFYING THERAPEUTIC PROTEIN TARGETS AT THE SURFACE OF CELLS EXPRESSING ONCOGENIC K-RAS PROTEIN AND USES THEREOF

  • Read more about METHODS OF IDENTIFYING THERAPEUTIC PROTEIN TARGETS AT THE SURFACE OF CELLS EXPRESSING ONCOGENIC K-RAS PROTEIN AND USES THEREOF
US Application 62/149,456
Filed on 2015-04-17

Methods of Isolating T Cells and T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation From Peripheral Blood

  • Read more about Methods of Isolating T Cells and T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation From Peripheral Blood
US Application 62/155,830
Filed on 2015-05-01

Multifunctional Molecule and Uses Thereof

  • Read more about Multifunctional Molecule and Uses Thereof
US Application 62/136,962
Filed on 2015-03-23

Extension Of Replicative Lifespan In Diseases Of Premature Aging Using P53 Isoforms

  • Read more about Extension Of Replicative Lifespan In Diseases Of Premature Aging Using P53 Isoforms
US Application 62/168,289
Filed on 2015-05-29

HYPOXIA-INDUCIBLE FACTOR 1 HIF-1 INHIBITORS

  • Read more about HYPOXIA-INDUCIBLE FACTOR 1 HIF-1 INHIBITORS
US Application 62/144,182
Filed on 2015-04-07

Dual Specific Anti-CD22-ANtiCD19 Chimeric Antigen

  • Read more about Dual Specific Anti-CD22-ANtiCD19 Chimeric Antigen
US Application 62/135,442
Filed on 2015-03-19

Defucosylated Bispecific Multivalent Fusion Proteins

  • Read more about Defucosylated Bispecific Multivalent Fusion Proteins
US Application 62/138,003
Filed on 2015-03-25

EPIDERMAL GROWTH FACTOR RECEPTOR 1 (EGFR1)-DERIVED MULTI-PEPTIDE COMPOSITIONS AND USES THEREOF

  • Read more about EPIDERMAL GROWTH FACTOR RECEPTOR 1 (EGFR1)-DERIVED MULTI-PEPTIDE COMPOSITIONS AND USES THEREOF
US Application 62/146,601
Filed on 2015-04-13

Display Platform From Bacterial Spore Coat Proteins

  • Read more about Display Platform From Bacterial Spore Coat Proteins
US Application 62/127,738
Filed on 2015-03-03

HIV Env Conserved Element DNA Vaccine

  • Read more about HIV Env Conserved Element DNA Vaccine
US Application 62/161,123
Filed on 2015-05-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health